TrialJournal of translational medicine2012

Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study.

Charles Kunos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.